Status | Study |
RECRUITING |
Study Name: Ice Plant Intensive Cream for the Prevention of Hand-Foot Syndrome in Breast Cancer: Pilot Randomized Controlled Trial Condition: Hand-Foot Syndrome Date: 2023-01-30 Interventions: This group receives a 30-minute nursing consultation on the standard treatment according to the guideline "Supportive Therapy" for hand-foot |
Completed |
Study Name: Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail Condition: Hepatocellular Carcinoma Date: 2016-11-06 Interventions: Drug: Celecoxib Patients from |
Not yet recruiting |
Study Name: Treatment of Hand and Foot Syndrome With Traditional Chinese Medicine Formula LC09 in Patients Who Are Receiving Capecitabine for Colorectal and/or Breast Cancer Condition: Hand Foot Syndrome Date: 2016-05-26 Interventions: Drug: Traditional Chinese Medicine Formula LC09 |
Recruiting |
Study Name: Study On Fatigue- And Hand-Foot Syndrome-Related Quality Of Life In Patients With Metastatic Renal Cell Carcinoma Receiving A Tyrosine Kinase Inhibitor as First-Line Treatment Condition: Metastatic Renal Cell Carcinoma Date: 2016-05-17 |
Recruiting |
Study Name: The Topical Application of Vitamin B6 in Palmar-Plantar Erythrodysesthesia Condition: Palmar-Plantar Erythrodysesthesia Date: 2015-12-05 Interventions: Device: Vitamin B6 cream Topic |
Recruiting |
Study Name: Testing the Effectiveness of Henna on Managing PPE Condition: Palmar-plantar Erythrodysesthesia (PPE) Date: 2012-12-14 Interventions: Drug: Henna Drug: Placebo |
No longer available |
Study Name: A Randomized, Open-label Phase III Trial of Mapisal® Versus an Urea Hand-foot Cream as Prophylaxis for Capecitabine-induced Hand-foot Syndrome in Patients With Gastrointestinal Tumors or Breast Cancer Condition: the Treatment Hand-foot Syndrome Patients With Gastrointestinal Tumors or Breast Cancer, Who Are Treated With Capecitabine Date: 2012-06-21 Interventions: Device: Mapisal Mapisal® |
Completed |
Study Name: Effectiveness Allopurinol Topical Agent Prevention Capecitabine-induced Hand-foot Syndrome Condition: Hand-foot Syndrome Date: 2012-05-24 Interventions: Drug: Allopurinol Allopurinol |
Completed |
Study Name: Safety and Efficacy Placebo Controlled Study of ATH008 Cream in PPES Patients Secondary to Capecitabine Condition: Palmar-Plantar Erythrodysesthesia Syndrome Date: 2011-03-14 Interventions: Drug: ATH008 The subject will be incorporated in the study and randomised to ATH008 cream 3% or 8% or AT |
Completed |
Study Name: Prevention of Capecitabine Induced Hand and Foot Syndrome Condition: Cancer Date: 2011-02-07 Interventions: Device: socks containing copper-oxide fibers The patients will use a sock which contains copper fibers. |